Arcutis Biotherapeutics (ARQT) Insider Trading & Ownership $14.62 -0.19 (-1.28%) Closing price 04:00 PM EasternExtended Trading$14.86 +0.25 (+1.68%) As of 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$7,771.23Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$2.21 M Get ARQT Insider Trade Alerts Want to know when executives and insiders are buying or selling Arcutis Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ARQT Insider Buying and Selling by Quarter Remove Ads Arcutis Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/3/2025Howard G WelgusDirectorSell10,000$13.00$130,000.00 3/3/2025Patrick BurnettInsiderSell2,819$13.03$36,731.57 2/3/2025Howard G WelgusDirectorSell10,000$12.71$127,100.00 2/3/2025Masaru MatsudaInsiderSell8,338$12.70$105,892.60 1/2/2025Howard G WelgusDirectorSell10,000$14.67$146,700.00 12/31/2024Patrick BurnettInsiderSell1,691$14.00$23,674.00 12/20/2024Todd Franklin WatanabeInsiderSell15,000$15.17$227,550.00 12/2/2024Howard G WelgusDirectorSell10,000$12.51$125,100.00 11/30/2024Larry Todd EdwardsInsiderBuy1,093$7.11$7,771.23 11/22/2024Patrick BurnettInsiderSell16,023$10.14$162,473.22 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/19/2024Masaru MatsudaInsiderSell1,775$9.68$17,182.00 11/15/2024Patrick BurnettInsiderSell100$10.03$1,003.00 11/11/2024Terrie CurranDirectorSell8,687$10.85$94,253.95 11/4/2024Masaru MatsudaInsiderSell5,015$8.68$43,530.20 11/1/2024Howard G WelgusDirectorSell10,000$8.65$86,500.00 10/2/2024Larry Todd EdwardsSVPSell3,725$10.01$37,287.25 10/1/2024Howard G WelgusDirectorSell10,000$9.26$92,600.00 9/24/2024David Joseph TopperCFOSell11,626$9.48$110,214.48 9/3/2024Howard G WelgusDirectorSell10,000$10.77$107,700.00 8/19/2024Patrick BurnettInsiderSell1,728$8.29$14,325.12 8/2/2024Masaru MatsudaInsiderSell5,220$9.02$47,084.40 8/1/2024Howard G WelgusDirectorSell10,000$9.87$98,700.00 7/1/2024Howard G WelgusDirectorSell10,000$9.31$93,100.00 5/30/2024Patrick BurnettInsiderSell23,000$8.75$201,250.00 5/28/2024Masaru MatsudaInsiderSell1,775$9.01$15,992.75 5/17/2024Larry Todd EdwardsSVPSell7,640$8.98$68,607.20 (Data available from 1/1/2013 forward) ARQT Insider Trading Activity - Frequently Asked Questions Who is on Arcutis Biotherapeutics's Insider Roster? The list of insiders at Arcutis Biotherapeutics includes David Joseph Topper, David W Osborne, Howard G Welgus, Larry Todd Edwards, Life Sciences Viii L Frazier, Masaru Matsuda, Orbimed Advisors Llc, Patricia A Turney, Patrick Burnett, Scott L Burrows, Terrie Curran, and Todd Franklin Watanabe. Learn more on insiders at ARQT. What percentage of Arcutis Biotherapeutics stock is owned by insiders? 9.50% of Arcutis Biotherapeutics stock is owned by insiders. Learn more on ARQT's insider holdings. Which Arcutis Biotherapeutics insiders have been buying company stock? The following insiders have purchased ARQT shares in the last 24 months: Larry Todd Edwards ($7,771.23), and Life Sciences Viii L Frazier ($200,000.00). How much insider buying is happening at Arcutis Biotherapeutics? Insiders have purchased a total of 81,093 ARQT shares in the last 24 months for a total of $207,771.23 bought. Which Arcutis Biotherapeutics insiders have been selling company stock? The following insiders have sold ARQT shares in the last 24 months: David Joseph Topper ($110,214.48), Howard G Welgus ($1,228,330.00), Larry Todd Edwards ($105,894.45), Masaru Matsuda ($289,430.15), Patrick Burnett ($455,446.61), Terrie Curran ($94,253.95), and Todd Franklin Watanabe ($227,550.00). How much insider selling is happening at Arcutis Biotherapeutics? Insiders have sold a total of 231,532 Arcutis Biotherapeutics shares in the last 24 months for a total of $2,511,119.64 sold. Arcutis Biotherapeutics Key ExecutivesMr. Todd Franklin Watanabe M.A. (Age 56)President, CEO & Director Compensation: $1.01M1 recent tradesDr. Bhaskar Chaudhuri Ph.D. (Age 69)Co-Founder & Independent Director Compensation: $60.83kDr. Patrick E. Burnett M.D. (Age 52)Ph.D., Senior VP & Chief Medical Officer Compensation: $722.94kMr. L. Todd Edwards (Age 60)Senior VP & Chief Commercial Officer Compensation: $755.64k2 recent tradesMr. David J. Topper (Age 66)Senior VP & Chief Financial Officer Mr. Rajvir MadanChief Digital & Technology OfficerMs. Latha VairavanVice President of Finance & Investor RelationsMs. Courtney Barton (Age 41)VP and Chief Compliance Officer & Privacy Officer Mr. Masaru Matsuda Esq. (Age 53)J.D., Senior VP, General Counsel & Corporate Secretary Compensation: $626.22k3 recent tradesMs. Amanda SheldonHead of Corporate Communications More Insider Trading Tools from MarketBeat Related Companies TG Therapeutics Insider Ownership BridgeBio Pharma Insider Ownership Axsome Therapeutics Insider Ownership Blueprint Medicines Insider Ownership Grifols Insider Ownership Elanco Animal Health Insider Ownership Krystal Biotech Insider Ownership Cytokinetics Insider Ownership Verona Pharma Insider Ownership Nuvalent Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles SentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It MattersInsider Scoop: 4 Stocks Insiders Are Buying and Selling2 Stocks Insiders Are Buying and 1 They're Selling3 Stocks With Robust Growth Outlooks Insiders Are Buying This page (NASDAQ:ARQT) was last updated on 3/14/2025 by MarketBeat.com Staff From Our PartnersTrump Shock to change everything Is this Trump’s next major move? Millionaire trading expert Imre Gams has found a bill that directs the Uni...Centurion Publishing | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredLying in hospital… staring at the light"Please don’t die on me," the nurse begged as Porter Stansberry lay in a hospital bed, his heart stopped from ...Porter & Company | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredOur #1 Defense Stock for MarchChina just deepened its military alliance with America's enemies in the Middle East... By conducting joint ...Behind the Markets | SponsoredElon’s desperate gambleWarning: "DOGE Collapse" Imminent After months of cost-cutting, controversy, and media buzz, DOGE is on the...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcutis Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcutis Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
